← Back

DoW Lung Cancer Translational Research Award

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.

Amount
Not stated
Type
Grant

Key facts

Key facts for DoW Lung Cancer Translational Research Award
AmountNot stated
IssuerDefense Health Agency Contracting Activity - DHACA
Who can applyAny organisation
SectorsDeep Tech
DeadlineClosed 02 Sep 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 40 days ago

  1. 85 days agoagentImported from the official source